Dong Li1, Christopher T Gordon2,3, Myriam Oufadem2,3, Jeanne Amiel2,3,4, Harsh S Kanwar5, Marina Bakay1, Tiancheng Wang1, Hakon Hakonarson1,6, Michael A Levine5,6,7. 1. Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 2. Laboratory of Embryology and Genetics of Congenital Malformations, INSERM UMR 1163, Institut Imagine, Paris, France. 3. Paris Descartes, Sorbonne Paris Cité Université, Institut Imagine, Paris, France. 4. Service de Génétique, Hôpital Necker-Enfants Malades, Assistance Publique ‒ Hôpitaux de Paris, Paris, France. 5. Center for Bone Health, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 6. Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. 7. Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Abstract
Context: Most cases of autosomal dominant isolated hypoparathyroidism are caused by gain-of-function mutations in CASR or GNA11 or dominant negative mutations in GCM2 or PTH. Objective: To identify the genetic etiology for dominantly transmitted isolated hypoparathyroidism in two multigenerational families with 14 affected family members. Methods: We performed whole exome sequencing of DNA from two families and examined the consequences of mutations by minigene splicing assay. Results: We discovered disease-causing mutations in both families. A splice-altering mutation in TBX1 (c.1009+1G>C) leading to skipping of exon 8 (101 bp) was identified in 10 affected family members and five unaffected subjects of family A, indicating reduced penetrance for this point mutation. In a second family from France (family B), we identified another splice-altering mutation (c.1009+2T>C) adjacent to the mutation identified in family A that results in skipping of the same exon; two subjects in family B had isolated hypoparathyroidism, whereas a third subject manifested the clinical triad of the 22q11.2 deletion syndrome, indicative of variable expressivity. Conclusions: We report evidence that heterozygous TBX1 mutations can cause isolated hypoparathyroidism. This study adds knowledge to the increasingly expanding list of causative and candidate genes in isolated hypoparathyroidism.
Context: Most cases of autosomal dominant isolated hypoparathyroidism are caused by gain-of-function mutations in CASR or GNA11 or dominant negative mutations in GCM2 or PTH. Objective: To identify the genetic etiology for dominantly transmitted isolated hypoparathyroidism in two multigenerational families with 14 affected family members. Methods: We performed whole exome sequencing of DNA from two families and examined the consequences of mutations by minigene splicing assay. Results: We discovered disease-causing mutations in both families. A splice-altering mutation in TBX1 (c.1009+1G>C) leading to skipping of exon 8 (101 bp) was identified in 10 affected family members and five unaffected subjects of family A, indicating reduced penetrance for this point mutation. In a second family from France (family B), we identified another splice-altering mutation (c.1009+2T>C) adjacent to the mutation identified in family A that results in skipping of the same exon; two subjects in family B had isolated hypoparathyroidism, whereas a third subject manifested the clinical triad of the 22q11.2 deletion syndrome, indicative of variable expressivity. Conclusions: We report evidence that heterozygous TBX1 mutations can cause isolated hypoparathyroidism. This study adds knowledge to the increasingly expanding list of causative and candidate genes in isolated hypoparathyroidism.
Authors: Michael Mannstadt; Mark Harris; Bert Bravenboer; Sridhar Chitturi; Koen M A Dreijerink; David G Lambright; Elaine T Lim; Mark J Daly; Stacey Gabriel; Harald Jüppner Journal: N Engl J Med Date: 2013-06-27 Impact factor: 91.245
Authors: Ruti Parvari; Eli Hershkovitz; Nili Grossman; Rafael Gorodischer; Bart Loeys; Alexandra Zecic; Geert Mortier; Simon Gregory; Reuven Sharony; Marios Kambouris; Nadia Sakati; Brian F Meyer; Aida I Al Aqeel; Abdul Karim Al Humaidan; Fatma Al Zanhrani; Abdulrahman Al Swaid; Johara Al Othman; George A Diaz; Rory Weiner; K Tahseen S Khan; Ronald Gordon; Bruce D Gelb Journal: Nat Genet Date: 2002-10-21 Impact factor: 38.330
Authors: K Nagamine; P Peterson; H S Scott; J Kudoh; S Minoshima; M Heino; K J Krohn; M D Lalioti; P E Mullis; S E Antonarakis; K Kawasaki; S Asakawa; F Ito; N Shimizu Journal: Nat Genet Date: 1997-12 Impact factor: 38.330
Authors: B Funke; J A Epstein; L K Kochilas; M M Lu; R K Pandita; J Liao; R Bauerndistel; T Schüler; H Schorle; M C Brown; J Adams; B E Morrow Journal: Hum Mol Genet Date: 2001-10-15 Impact factor: 6.150
Authors: Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett Journal: Nat Rev Dis Primers Date: 2015-11-19 Impact factor: 52.329
Authors: Tatjana Piotrowski; Dae-gwon Ahn; Thomas F Schilling; Sreelaja Nair; Ilya Ruvinsky; Robert Geisler; Gerd-Jörg Rauch; Pascal Haffter; Leonard I Zon; Yi Zhou; Helen Foott; Igor B Dawid; Robert K Ho Journal: Development Date: 2003-10 Impact factor: 6.868
Authors: D M McDonald-McGinn; M K Tonnesen; A Laufer-Cahana; B Finucane; D A Driscoll; B S Emanuel; E H Zackai Journal: Genet Med Date: 2001 Jan-Feb Impact factor: 8.822
Authors: Malak Alghamdi; Reem Al Khalifah; Doua K Al Homyani; Waleed H Alkhamis; Stefan T Arold; Aishah Ekhzaimy; Mohammed El-Wetidy; Tarek Kashour; Rabih Halwani Journal: J Endocr Soc Date: 2019-11-29